Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Healthy Alaskan.
Press releases published on June 24, 2025
Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures
GlobeNewswire
·
June 24, 2025
The future of fracture fixation with novel side-specific nails featuring variable angle locking technology Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its new TRIGEN MAX Tibia Nailing System for …
Peter Gilgan investing $60 million to build extraordinary at St. Joseph's Health Centre
GlobeNewswire
·
June 24, 2025
PETER GILGAN GIVES DEEPLY PERSONAL GIFT TO ST. JOE’S TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Peter Gilgan, founder and CEO of Mattamy Asset Management (the parent company of Mattamy Homes), is paying tribute to his deep roots in Toronto’s west end with …
USAging Announces New Public Awareness Campaign to Raise Visibility of Area Agencies on Aging
GlobeNewswire
·
June 24, 2025
Washington, DC, June 24, 2025 (GLOBE NEWSWIRE) -- USAging is celebrating 50 years as the national organization that represents Area Agencies on Aging (AAAs) and Title VI Native American Aging Programs. As part of the 50th anniversary, USAging has launched …
Rebirth Globe Launches Global Expansion Across the Americas and Middle East, Welcomes International Medical Expert Miss Lucy Yang
GlobeNewswire
·
June 24, 2025
Rebirth Logo NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Rebirth Globe, a pioneering leader in advanced aesthetic device technology, proudly announces its strategic expansion into North America, South America, and the Middle East, marking a transformative …
Olympia Pharmaceuticals Launches OlympiaYou.com: Empowering Patients Through Innovative Wellness and Sexual Health Support
GlobeNewswire
·
June 24, 2025
ORLANDO, Fla., June 24, 2025 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, the nation’s leading 503A and 503B compounding pharmacy, is proud to announce the launch of its new consumer-focused platform, OlympiaYou.com – a new digital platform designed to …
Actuate Therapeutics Highlights Significant and Sustained Survival Benefit in Key Metastatic Pancreatic Cancer Patient Populations in Phase 2 Elraglusib Trial
GlobeNewswire
·
June 24, 2025
- Near doubling of 1-year overall survival (OS), increased median OS of 4 months (12.5 vs 8.5 months), and 43% reduction in risk of death in patients treated with at least one cycle (4 weeks) of elraglusib plus gemcitabine/nab-paclitaxel (GnP) vs GnP alone …
Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health
GlobeNewswire
·
June 24, 2025
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that it is adding pelvic floor therapy to its comprehensive offering of women’s health and family …
Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock
GlobeNewswire
·
June 24, 2025
NEEDHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, has …
SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy
GlobeNewswire
·
June 24, 2025
Cincinnati Children’s Hospital Medical Center Discusses QUELIMMUNE Therapy Adoption A Father and Patient Describe Their Real-Life Experience with the QUELIMMUNE Therapy DENVER, June 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: …
Celia Huber Joins AMN Healthcare Board of Directors
GlobeNewswire
·
June 24, 2025
DALLAS, June 24, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, announced the election of Celia Huber to its Board of Directors during its annual meeting of shareholders …
Innovate GBM Rings the NASDAQ Closing Bell in Honor of Brain Tumor Patients and Community
GlobeNewswire
·
June 24, 2025
LOS ANGELES, June 24, 2025 (GLOBE NEWSWIRE) -- Innovate GBM, a 501(c)(3) nonprofit organization dedicated to transforming the future of brain tumor research and treatment through collaboration, infrastructure, and strategic investment, rang the NASDAQ …
Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program
GlobeNewswire
·
June 24, 2025
Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program Funding to support MOCART, a clinical programme evaluating mocravimod added to standard CAR-T cell therapy Saint-Louis, France and Dublin, Ireland – 24 June …
Distalmotion Achieves Milestone in the US as AdventHealth Acquires Multiple DEXTER® Robotic Surgery Systems
GlobeNewswire
·
June 24, 2025
Lausanne, Switzerland, June 24, 2025 (GLOBE NEWSWIRE) -- Distalmotion, a global MedTech company advancing access to robotic surgery, has reached a key milestone in its US expansion with the first multi-robot sale in the country. AdventHealth, which …
Green Tree Pediatrics is Now Part of the Zarminali Pediatrics, Signaling New Chapter of Care and Community Commitment
GlobeNewswire
·
June 24, 2025
ANN ARBOR, Mich., June 24, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics, the first outpatient pediatric destination purpose-built to provide elevated, seamlessly coordinated primary and specialty care nationwide, announced that Green Tree Pediatrics has …
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
GlobeNewswire
·
June 24, 2025
FDA has indicated that an Advisory Committee meeting is not required at this time In-person late-cycle review meeting scheduled for mid-July Biologics License Application (BLA) remains under Priority Review with PDUFA target action date of August 31, 2025 …
Senti Bio to Present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference
GlobeNewswire
·
June 24, 2025
SOUTH SAN FRANCISCO, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Journey Medical to Join Russell 2000® and Russell 3000® Indexes
GlobeNewswire
·
June 24, 2025
SCOTTSDALE, Ariz., June 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or the “Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and …
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome
GlobeNewswire
·
June 24, 2025
ASHBURN, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug …
CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer
GlobeNewswire
·
June 24, 2025
VANCOUVER, Washington, June 24, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that …
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
GlobeNewswire
·
June 24, 2025
VANCOUVER, British Columbia and BOSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …